Real-world use and outcomes of belimumab in childhood-onset lupus: A single-center retrospective study

Jordan E. Roberts, Mary Beth F. Son(Boston Children's Hospital), Emily A. Smitherman(Children's of Alabama), Scott E. Wenderfer, Rebecca E. Sadun(Duke University), Cordelia Burn(Boston Children's Hospital)
Lupus
July 6, 2023
10.1177/09612033231187752
Cited by 17

Related Papers

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
|JAMA|2021|852
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
|Arthritis & Rheumatology|2020|537
Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series
|Arthritis & Rheumatism|2010|465
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2
|Arthritis & Rheumatology|2020|415